Literature DB >> 27837197

Comparison of ethnicity, gender, age of onset and outcome in South Africans with systemic lupus erythematosus.

A Budhoo1, G M Mody1, T Dubula1,2, N Patel1, P G Mody3.   

Abstract

Ethnicity, gender and age of onset are reported to influence the expression and outcome of systemic lupus erythematosus. We studied a multi-ethnic cohort of 408 South Africans (91.2% females) comprising 237 (58.1%) Indians, 137 (33.6%) African Blacks, 17 (4.2%) Mixed ethnicity and 17 (4.2%) Whites. The most common manifestations were arthritis (80.6%), photosensitivity (67.2%), oral ulcers (50.0%), malar rash (49.0%) and renal (39.2%). The common laboratory findings were positive anti-nuclear factor (96.8%), haematological (74.8%) and anti-dsDNA antibodies (45.3%). Serositis ( p = 0.002), nephritis ( p = 0.039), leucopaenia ( p = 0.001), haemolytic anaemia ( p = 0.026), anti-dsDNA antibodies ( p = 0.028) and anti-Sm antibodies ( p = 0.050) were more common in African Blacks compared to Indians. Males had increased prevalence of discoid rash ( p = 0.006) and anti-Sm antibodies ( p = 0.016). Discoid rash ( p = 0.018), renal involvement ( p < 0.001), psychosis ( p = 0.028), seizures ( p = 0.020), anti-dsDNA antibodies ( p = 0.009), leucopaenia ( p = 0.006), haemolytic anaemia ( p = 0.017) and thrombocytopaenia ( p = 0.023) were more common with early-onset systemic lupus erythematosus. On multivariate analysis, the independent predictors of death were renal involvement, anti-dsDNA antibodies and seizures. There were 53 (13%) deaths and the five- and 10-year survival was 90.8% and 85.7% respectively, with no differences related to ethnicity or age of onset. In conclusion, we report on the spectrum and outcome of systemic lupus erythematosus in a large South African multi-ethnic cohort.

Entities:  

Keywords:  African Blacks; Indians; Systemic lupus erythematosus; deaths; early-onset SLE; ethnicity; gender; late-onset SLE; outcome; survival

Mesh:

Year:  2016        PMID: 27837197     DOI: 10.1177/0961203316676380

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

1.  Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus.

Authors:  Sung Soo Ahn; Seung Min Jung; Juyoung Yoo; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park
Journal:  Rheumatol Int       Date:  2019-09-24       Impact factor: 2.631

Review 2.  Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management.

Authors:  Oshrat E Tayer-Shifman; Kathleen S Bingham; Zahi Touma
Journal:  Drugs Aging       Date:  2021-12-16       Impact factor: 3.923

3.  Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons.

Authors:  Sahwa Elbagir; Amir I Elshafie; Elnour M Elagib; NasrEldeen A Mohammed; Mawahib I E Aledrissy; Azita Sohrabian; Musa A M Nur; Elisabet Svenungsson; Iva Gunnarsson; Johan Rönnelid
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

4.  Epidemiological data on systemic lupus erythematosus in native sub-Saharan Africans.

Authors:  Mickael Essouma; Jan René Nkeck; Francky Teddy Endomba; Jean Joel Bigna; Madeleine Singwe-Ngandeu; Eric Hachulla
Journal:  Data Brief       Date:  2019-11-27

Review 5.  Rheumatic diseases in Africa.

Authors:  Olufemi Adelowo; Girish M Mody; Mohammed Tikly; Omondi Oyoo; Samy Slimani
Journal:  Nat Rev Rheumatol       Date:  2021-04-13       Impact factor: 20.543

Review 6.  Global epidemiology of systemic lupus erythematosus.

Authors:  Megan R W Barber; Cristina Drenkard; Titilola Falasinnu; Alberta Hoi; Anselm Mak; Nien Yee Kow; Elisabet Svenungsson; Jonna Peterson; Ann E Clarke; Rosalind Ramsey-Goldman
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 32.286

7.  Evidence of a distinct group of Black African patients with systemic lupus erythematosus.

Authors:  Elopy N Sibanda; Margo Chase-Topping; Lorraine T Pfavayi; Mark E J Woolhouse; Francisca Mutapi
Journal:  BMJ Glob Health       Date:  2018-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.